We recently published an article titled Why These 10 Stocks Soared Today. In this article, we are going to take a look at ...

Verona Pharma (NASDAQ:VRNA)'s stock has reached an unprecedented peak, setting an all-time high at $56.49. This milestone underscores a remarkable period of growth for the $4.49 billion ...

(RTTNews) - Verona Pharma plc (VRNA), Friday announced some ... up 1.98 percent on the Nasdaq. The views and opinions expressed herein are the views and opinions of the author and do not ...

In Greater China, Verona has an existing collaboration with Nuance Pharma. There, Verona is eligible for another $179 million in milestone payments, and tiered double-digit royalties on net sales ...

LONDON and RALEIGH, N.C., April 29, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona” or the “Company”), a biopharmaceutical company focused on respiratory diseases ...

HighTower Advisors LLC decreased its holdings in shares of Verona Pharma plc (NASDAQ:VRNA – Free Report) by 5.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC.

On Monday, TD Cowen initiated coverage on Verona Pharma (NASDAQ:VRNA), which trades on the NASDAQ with a market capitalization of $5.56 billion, with an optimistic outlook. Analyst Tara Bancroft ...

LONDON and RALEIGH, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that it will report its financial results for the first ...